According to a new report by Polaris Market Research, the global epilepsy drugs market was valued at USD 11.81 billion in 2025 and is projected to reach USD 19.45 billion by 2034, expanding at a CAGR of 5.70% over the forecast period. Growth is underpinned by rising epilepsy prevalence, growing awareness of treatment options, and accelerating third-generation antiepileptic drug (AED)...